NVUS - Novus Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 527.63M
Enterprise Value 38.54M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.31
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.63

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Sep 30, 2017


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-25.85%
Return on Equity (ttm)-129.06%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-8.89M
Diluted EPS (ttm)-2.51
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)19.09M
Total Cash Per Share (mrq)2.69
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)9.12
Book Value Per Share (mrq)2.97

Cash Flow Statement

Operating Cash Flow (ttm)-13.61M
Levered Free Cash Flow (ttm)-2.69M

Trading Information

Stock Price History

Beta 0.83
52-Week Change 3-56.67%
S&P500 52-Week Change 323.60%
52 Week High 39.27
52 Week Low 33.42
50-Day Moving Average 34.06
200-Day Moving Average 34.38

Share Statistics

Avg Vol (3 month) 39.54k
Avg Vol (10 day) 37.1k
Shares Outstanding 57.09M
Float 1.56M
% Held by Insiders 129.76%
% Held by Institutions 153.27%
Shares Short 346.08k
Short Ratio 33.06
Short % of Float 31.79%
Shares Short (prior month) 368.61k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/9
Last Split Date 3May 11, 2017